In renal vascular disease, intrarenal administration of VEGF can stimulate microvascular repair and improve microvascular density, which suggests that using vascular endothelial growth factor (VEGF) to stimulate renal microvascular repair may be a feasible strategy for chronic kidney disease (CKD) [96]. The gene discussed is VEGFA; the disease is chronic kidney disease.